Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Homologous cancer cell membrane-camouflaged nanoparticles target drug delivery and enhance the chemotherapy efficacy of hepatocellular carcinoma
Yahui Wu, Rongtao Zhu, Mengyang Zhou, et al.
Cancer Letters (2023) Vol. 558, pp. 216106-216106
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform
Qiuyan Guo, Shengmei Wang, Rubing Xu, et al.
RSC Advances (2024) Vol. 14, Iss. 15, pp. 10608-10637
Open Access | Times Cited: 19
Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer
Wei Zhang, Yibao Fan, Jinze Zhang, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101005-101005
Open Access | Times Cited: 30
Biomembrane‐coated nanosystems as next‐generation delivery systems for the treatment of gastrointestinal cancers
Joana Lopes, Daniela Lopes, Mahzad Motallebi, et al.
Bioengineering & Translational Medicine (2025)
Open Access | Times Cited: 1
Brain gliomas: Diagnostic and therapeutic issues and the prospects of drug-targeted nano-delivery technology
Baoqin Song, Xiu Wang, Lijing Qin, et al.
Pharmacological Research (2024) Vol. 206, pp. 107308-107308
Open Access | Times Cited: 8
Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity
Qiang You, Rong Li, Jia Yao, et al.
Medical Oncology (2024) Vol. 41, Iss. 3
Closed Access | Times Cited: 7
Emerging platelet-based drug delivery systems
Mengkun Fang, Rui Liu, Yile Fang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117131-117131
Open Access | Times Cited: 7
A structured biomimetic nanoparticle as inflammatory factor sponge and autophagy-regulatory agent against intervertebral disc degeneration and discogenic pain
Kanglu Li, Wenbo Yang, Xuanzuo Chen, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment
Yunan Gu, Lixin Du, Yuxin Wu, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 960-960
Open Access | Times Cited: 5
Nanomaterials: leading immunogenic cell death-based cancer therapies
Changyu Ma, Zhe Cheng, Haotian Tan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives
Yuhang Chen, Shengyuan Dai, Chien‐shan Cheng, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
MRI-guided cell membrane-camouflaged bimetallic coordination nanoplatform for combined tumor phototherapy
Mengyang Zhou, Yifei Wang, Yaning Xia, et al.
Materials Today Bio (2024) Vol. 26, pp. 101019-101019
Open Access | Times Cited: 4
A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy
Wenjie Xie, Yuting Zhang, Qianfeng Xu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3957-3972
Open Access | Times Cited: 4
Advances in cell membrane-based biomimetic nanodelivery systems for natural products
Yifeng Zhang, Qian Zhang, Chunhong Li, et al.
Drug Delivery (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 4
Preparation of Biomimetic Selenium–Baicalein Nanoparticles and Their Targeted Therapeutic Application in Nonsmall Cell Lung Cancer
Huan Shi, Biaobiao Wang, Huilin Ma, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4476-4489
Closed Access | Times Cited: 4
Targeted Drug Delivery Strategies for the Treatment of Hepatocellular Carcinoma
Yonghui Liu, Yanan Wu, Zijian Li, et al.
Molecules (2024) Vol. 29, Iss. 18, pp. 4405-4405
Open Access | Times Cited: 4
Diversified nanocarrier design to optimize glucose oxidase-mediated anti-tumor therapy: Strategy and progress
Yuhan Fu, Jialin Sun, Chunyu Yang, et al.
International Journal of Biological Macromolecules (2025), pp. 141581-141581
Closed Access
Sorafenib—Drug Delivery Strategies in Primary Liver Cancer
Piotr Szyk, Beata Czarczyńska-Goślińska, Marta Ziegler-Borowska, et al.
Journal of Functional Biomaterials (2025) Vol. 16, Iss. 4, pp. 148-148
Open Access
Endocytosis: the match point of nanoparticle-based cancer therapy
Yonglu Li, Xin Gao, Yapeng Li, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 38, pp. 9435-9458
Closed Access | Times Cited: 3
Progress in the Application of Novel Nanomaterials in Targeted Therapy for Liver Cancer
Xin Wei, Weihua Cao, Shiyu Wang, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2623-2643
Open Access
Cancer cell membrane-camouflaged pH-responsive nanoparticles for enhancing siRNA effect and synergistic anti-tumor therapy
Jie Zhang, Xia Li, Qi Sun, et al.
Research Square (Research Square) (2025)
Closed Access
Strategies and Recent Advances on Improving Efficient Antitumor of Lenvatinib Based on Nanoparticle Delivery System
Haiqing Wang, Wentao Bo, Xielin Feng, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 5581-5603
Open Access | Times Cited: 3
Cell-nanocarrier drug delivery system: a promising strategy for cancer therapy
Jiefen Yang, Xiongxi Shi, Yanting Kuang, et al.
Drug Delivery and Translational Research (2023) Vol. 14, Iss. 3, pp. 581-596
Closed Access | Times Cited: 7
Cell Membrane Biomimetic Nano-Delivery Systems for Cancer Therapy
Zhenxing Xia, Weiwei Mu, Shijun Yuan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2770-2770
Open Access | Times Cited: 5
Macrophage hitchhiking for systematic suppression in postablative multifocal HCC
Xuehan Li, Yan Zhang, Shun Li, et al.
Hepatology (2024)
Closed Access | Times Cited: 1
Advances in Tumor Targeting Biomimetic Drug Delivery Systems: A Promising Approach for Antitumor Therapy
Ziyi Mo, Jiao He, Man Li, et al.
Pharmaceutical Fronts (2024) Vol. 06, Iss. 02, pp. e101-e118
Open Access
Page 1 - Next Page

Scroll to top